4.5 Review

Roles for Growth Factors in Cancer Progression

Journal

PHYSIOLOGY
Volume 25, Issue 2, Pages 85-101

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiol.00045.2009

Keywords

-

Categories

Funding

  1. Goldhirsh Foundation
  2. U.S. National Cancer Institute [CA072981]
  3. European Commission
  4. Israel Science Foundation
  5. German Research Foundation (DFG)
  6. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  7. Marc Rich Foundation for Education, Culture and Welfare
  8. M. D. Moross Institute for Cancer Research
  9. NATIONAL CANCER INSTITUTE [R37CA072981, R01CA072981] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Under physiological conditions, cells receive fate-determining signals from their tissue surroundings, primarily in the form of polypeptide growth factors. Integration of these extracellular signals underlies tissue homeostasis. Although departure from homeostasis and tumor initiation are instigated by oncogenic mutations rather than by growth factors, the latter are the major regulators of all subsequent steps of tumor progression, namely clonal expansion, invasion across tissue barriers, angiogenesis, and colonization of distant niches. Here, we discuss the relevant growth factor families, their roles in tumor biology, as well as the respective downstream signaling pathways. Importantly, cancer-associated activating mutations that impinge on these pathways often relieve, in part, the reliance of tumors on growth factors. On the other hand, growth factors are frequently involved in evolvement of resistance to therapeutic regimens, which extends the roles for polypeptide factors to very late phases of tumor progression and offers opportunities for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available